<DOC>
	<DOC>NCT01837446</DOC>
	<brief_summary>Oral mucositis is a debilitating side effects of cancer treatment for which there is not much successful treatments at yet. The investigators are going to evaluate the effectiveness of topical morphine compared with a routine mouthwash in managing cancer treatment-induced mucositis. The investigators hypothesize that topical morphine is more effective and more satisfied by patients than the magic mouthwash in reducing severity of cancer treatment-induced oral mucositis.</brief_summary>
	<brief_title>Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Aluminum hydroxide, magnesium hydroxide, drug combination</mesh_term>
	<mesh_term>Aluminum Hydroxide</mesh_term>
	<mesh_term>Magnesium Hydroxide</mesh_term>
	<criteria>Head and neck cancer patients Severe oral mucositis; grade III or IV of the World Health Organization (WHO) rating of global mucositis Willingness to participate History of severe renal or hepatic insufficiency Collagenvascular disease Allergic reaction to morphine Current smokers or alcohol users Pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>mucositis</keyword>
	<keyword>topical morphine</keyword>
	<keyword>pain</keyword>
	<keyword>head and neck carcinoma</keyword>
</DOC>